Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NILOTINIB vs NIMODIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NILOTINIB vs NIMODIPINE: Safety Overview

Metric NILOTINIB NIMODIPINE
Total FAERS Reports 23,171 416
Deaths Reported 4,543 32
Death Rate 19.6% 7.7%
Hospitalizations 4,846 158
Average Patient Age 56.5 yrs 53.9 yrs
% Female Patients 47.7% 62.3%
FDA Approval Date Dec 15, 2025 Apr 17, 2007
Manufacturer Novadoz Pharmaceuticals LLC Heritage Pharmaceuticals Inc. d/b/a A...
Route ORAL ORAL
Marketing Status Prescription Discontinued